Dolutegravir noninferior to a ritonavir-boosted protease inhibitor regimen for treating HIV
Bookmark1. In the randomized controlled trial, dolutegravir treatment was noninferior to a regimen containing a ritonavir-boosted protease inhibitor (PI) for treating human immunodeficiency virus (HIV). 2. Dolutegravir...
Read More